American Conference Institute (ACI) will be holding its Advanced Summit on Medical Device Patents on February 28-29, 2012 in Boston, MA. The conference will allow attendees to:
• Revamp patent prosecution and litigation strategies in view of new America Invents Act (AIA) procedures specifically affecting medical device companies;
• Draft and protect medical device diagnostic claims to withstand challenge in the wake of Bilski and its progeny;
• Develop global patent prosecution and litigation strategies to minimize risk and maximize device market share in emerging and established markets;
• Combat obviousness rejections in light of increasingly more stringent standards post-KSR and patent reform; and
• Assess device method patents' increasing vulnerability to joint infringement and inducement allegations post-McKesson.
In particular, ACI's faculty will offer presentations on the following topics:
• Device industry state of the union: Maximizing device patent life and strategic portfolio building in a game-changing year;
• PTO keynote: Integrating the America Invents Act into medical device patents practice -- presented by Teresa Stanek Rea, Deputy Director of the U.S. Patent and Trademark Office;
• The post-AIA world: Tailoring medical device patent strategies for litigation and PTO proceedings;
• Protecting diagnostic method claims post-Bilski: Lessons for prosecutors and litigators to comply with increasingly strict standards of patentability;
• Overcoming obviousness challenges: Evolving standards for evaluating validity for devices post-KSR;
• Resolving the written description / enablement dichotomy: Practical claim drafting strategies and litigation strategies post-Centocor;
• Maximizing market share in a global economy: Developing a plan for international medical device patent life cycle management;
• Proving or disproving inducement of infringement: Understanding McKesson's consequences for device method patents;
• Conducting effective freedom-to-operate searches: Guaranteeing the right to commercialize with certainty;
• Calculating and proving medical device damages and minimizing damages liability;
• Preparing your device portfolio for litigation: Limiting liability and managing and reducing costs; and
• Inequitable conduct: Navigating the crowded field of prior art for medical devices technology.
In addition, a pre-conference workshop entitled "Mastering the Intricacies of USPTO Practice Post-Patent Reform" will be offered from 9:00 am to 12:00 pm on February 27, 2012, and a second pre-conference workshop entitled "The 510(k) Process and Patentability: Reformulating Patent Strategies in Light of Changes in the Regulatory Approval Process" will be offered from 1:00 pm to 4:00 pm on February 27, 2012.
The agenda for the Drug and Medical Device Litigation conference can be found here. A complete brochure for this conference, including an agenda, detailed descriptions of conference sessions, list of speakers, and registration form can be obtained here.
The registration fee for the conference is $2,295 (conference alone), $2,895 (conference and one workshop), or $3,295 (conference and both workshops). Those registering by January 13, 2012 will receive a $300 discount, and those registering by February 3, 2012 will receive a $200 discount. In addition, Patent Docs readers who reference the discount code "PD 200" will receive $200 off the current price tier when registering. Those interested in registering for the conference can do so here, by calling 1-888-224-2480, or by faxing a registration form to 1-877-927-1563.
Patent Docs is a media partner of ACI's Medical Device Patents conference.
Comments